Our Partners
Trending Now
Features
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
T.A.C jubilance gets reverberated with Debutant of the year from India...
New Delhi, June 13, 2022: India's fastest-growing D2C brand in the natural healthcare industry, The Ayurveda Company aka T.A.C has clinched another glory by...
Workshop on Key Challenges and Regulatory Compliances for Pharma & Life...
Tamil Nadu Technology Development & Promotion Centre of CII in partnership with Ecolab organizing the Workshop on Key Challenges and Regulatory Compliances for Pharma...
Medical Tourism
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
POPULAR NEWS
- All
- Accreditation
- Acquisition
- Acts & Rules
- Affordable Medicines
- Alternative Medicine
- Appointment
- Appointment Advertisement
- Approval
- Archives
- Authors
- Awards
- Awareness
- Biotechnology
- Budget
- Bulk Drug
- Business News
- Buy & Sell Advertisement
- Cancer
- Child Health Care
- Classifiedes Bottom
- Clinical Research
- Clinical Trials
- Companies
- company
- Company News
- Company Profile
- conference
- Contract Research
- Cosmetics
- Dental Care
- Directory
- Diseases
- Doctors (D)
- Drug & Cosmetic at Act 1940
- Drug Discovery & Development
- Drug Research
- E-Magazine
- Editorial
- event
- Events
- Extras
- Eye Care
- Eye Care
- Featured
- Featured
- Financial Results
- Funding
- Gallery
- Generics Drug
- GMP Certification
- Health Care
- Health Insurance
- Healthcare
- Healthly Life Style
- Hearing Care
- Hospital Management
- Hospitals
- Hospitals (D)
- International
- Investment
- IT & Software Support
- Jobs
- Joint Venture
- Judgements
- Laboratories (D)
- Latest
- Launch
- Launches
- Licensing
- Livestock Health
- Loans
- Machinery/ Equipments
- Manufacturers (D)
- Manufacturing
- Manufacturing Applications (D)
- Market
- Marketing
- Media Partners
- Medical Colleges
- Medical Device Manufacturers
- Medical Device Manufacturers (D)
- Medical Devices
- Medical Education
- Medical Tourism
- Mental Health
- Mother's Health
- MoU
- National
- National
- New Launches
- News
- News Features
- News Reports
- Packaging
- Patents
- Pharma Awards
- Pharma Packaging Companies (D)
- Pharma Topics
- Pharma Update
- Policies & Regulations
More
Biotechnology
The Future is Here: MASSH Hospital Ushers in a New Era of Smart Healthcare
NEW DELHI , August 29, 2023: A ground-breaking chapter in the realm of healthcare has unfolded with the official launch of Minimal Access Smart...
IT & Software Support
Financial Results
Clinical Trails
Phase III DECISION Trial of Nexavar® (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival...
Berlin, January 3, 2013 – Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase III trial of Nexavar® (sorafenib) tablets in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory differentiated thyroid cancer has met its primary endpoint of a statistically significant improvement in progression-free survival. The study, called DECISION, evaluated the efficacy and safety of Nexavar compared to placebo. The safety and tolerability were generally consistent with the known profile of Nexavar. Detailed efficacy and safety analysis from this study are expected to be presented at an upcoming medical meeting. Effective treatment options are urgently needed for patients with RAI-refractory differentiated thyroid cancer,” said Dimitris Voliotis, MD, Vice President, Global Clinical Development Oncology, Bayer HealthCare. “We are pleased that the results of this study demonstrate that Nexavar may provide a treatment option for these patients.
Bulk Drug
Health Care
Alternative Medicine
Eye Care
Dr Shroff’s Charity Eye Hospital and Standard Chartered, to host the 1st International Optometry...
New Delhi, December 29, 2023 : Dr Shroff’s Charity Eye Hospital together with Standard Chartered is organising India’s first International Optometry and Vision Science...
Wearing glasses is the best option till the pandemic of COVID 19 is over...
By Dr. Kasu Prasad Reddy – Chief Surgeon and Founder of MaxiVision Eye Hospitals.
Covid19 virus is transmitted mainly via small respiratory droplets through...
Dr. Agarwals Eye Hospitals opens high-end eyecare facility in Chembur, its 10th in Mumbai
Mumbai, October 05, 2023: Dr. Agarwals Eye Hospitals has opened a state-of-the-art eyecare hospital in Chembur, Mumbai, at Signature Business Park. The facility, spread...
Spotlight
SCHOTT Glass wins top awards at vendor meet organized by Borosil Klasspack
02:48
Indian Pharmaceutical Market forecast 2016-2026
00:16
Indian Pharmaceutical Industry has emerged as 3rd largest producer in the world Pharmacy College
07:27
Pharmaceuticals Industry in India 2015 - 2020
02:36
India Pharma Awards 2015
25:11
Aurobindo Pharma Corporate Film
13:14
Pharmaceutical Industry in India
03:14
Made In India-Pharmaceutical Industry-2015
09:19
Dr. Sunil Chandy Speaking on the topic Scaling up tertiary care in hinterland India
28:45
Phases of Pharmaceutical Industry
13:49
Latest News
New State Of The Art Cleanroom Completed By Whp For Adc Bio
The GMP facility has been specifically designed to deliver the next generation of anticancer blockbuster ADC drugs for patients globally
New Delhi, July 15, 2019:...
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene...
Fermenta has signed a Definitive Agreement with Aurigene, a stepdown subsidiary of Dr Reddy's Laboratories Limited
Mumbai, January 20, 2022: Fermenta Biotech Limited (FBL) today...
Chronic Leukemia: Challenges, Treatments, and Quality of Life
Dr Vinod Sharma, Consultant - Medical Oncologist, HCG Cancer Centre, Jaipur
Leukemia is a type of cancer that affects the blood and bone marrow. It...
Benefits of Exercise for Strengthening Joints in Arthritis
Dr. J V Srinivas, Lead Consultant - Orthopedics & Joint Surgery, Aster RV Hospital
Exercise is one of the best ways of living an overall healthy...
Pre-Budget Expectations 2024-25
Mumbai, january 18, 2024 : Over the past few years, Government-run schemes, both at the Central and State levels, have gained popularity, such as Ayushman...
Dental Care
Hospital Management
Common Symptoms of Gallbladder Cancer: Recognizing the Signs
By Dr Satya Srinivas A, Consultant - Medical Oncologist, HCG Cancer Centre, Vijaywada
One of the most rare but serious forms of cancer is Gallbladder cancer...
Drug Discovery & Development
Bharat Biotech and University of Maryland Accelerate Development of New Life Saving Conjugate Vaccine...
Receive USD 4 Million Award from The Wellcome Trust for Development and Clinical Trials Hyderabad, India, June 18, 2012: Bharat Biotech and The University of Maryland Center for Vaccine Development (“CVD”) announced today a significant milestone achievement– receiving a USD 4 Million Strategic Translation Award from The Wellcome Trust for clinical development of a new conjugate vaccine including initial clinical trials beginning in three years to prevent the potentially lethal infectious disease caused by invasive non-typhoidal Salmonella (NTS). NTS have emerged as an important cause of invasive bloodstream infection in sub-Saharan Africa, among young children with malaria and malnutrition, and among adults with HIV. Strains of nontyphoidal Salmonella (“NTS”) that can cause systemic disease such as meningitis or sepsis are particularly common in sub-Saharan Africa; approximately 20 to 30% of children with such invasive NTS infections die.
Suppliers
Technology
Companies
Natural Remedies Launches Kamdhenu to Help Cows Recover Post Calving
Bengaluru, September 24, 2021: Bengaluru based Natural Remedies, one of the fastest growing Herbal healthcare companies in India has launched “Kamdhenu”, the herbal solution that...
Marketing
